Coherus BioSciences

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CHRS and other ETFs, options, and stocks.

About CHRS

Coherus BioSciences, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of biosimilar therapeutics. Its products include UDENYCA and Coherus COMPLETE. 

CEO
Denny M. Lanfear
CEODenny M. Lanfear
Employees
332
Employees332
Headquarters
Redwood City, California
HeadquartersRedwood City, California
Founded
2010
Founded2010
Employees
332
Employees332

CHRS Key Statistics

Market cap
529.67M
Market cap529.67M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
686.88K
Average volume686.88K
High today
$6.81
High today$6.81
Low today
$6.55
Low today$6.55
Open price
$6.70
Open price$6.70
Volume
847.85K
Volume847.85K
52 Week high
$18.38
52 Week high$18.38
52 Week low
$5.60
52 Week low$5.60

Analyst ratings

63%

of 8 ratings
Buy
62.5%
Hold
37.5%
Sell
0%

CHRS Earnings

-$1.00
-$0.65
-$0.29
$0.06
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Feb 16, After Hours
ActualExpected Feb 16, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.